Yunge Gao et al. have showed that CD44+ DC cells can enhance immune antitumor effects in ovarian cancer by inhibiting the suppressive effect of growth differentiation factor-15 (GDF-15) on CD11c, CD83 and CD86 expression [32]. The gene discussed is ITGAX; the disease is ovarian carcinoma.